Skip to main content

Acetamide-45 inhibited hyperresponsiveness and airway inflammation in mice partly depending on phosphodiesterase activity suppression

Buy Article:

$51.00 plus tax (Refund Policy)

Abstract:

Abstract

Aim: Asthma is characterized as a chronic inflammatory disorder of the airways. Phosphodiesterases (PDE), which hydrolyze cAMP, are considered to play important roles in asthma. We previously reported that acetamide-45 could inhibit cAMP-PDE activity, and histamine- and methacholine-induced contractions of isolated guinea pig trachea. The purpose of this study is to determine whether this agent could suppress allergic-induced airway hyperresponsiveness (AHR) and airway inflammation in allergic mice. Methods: A mouse model for asthma was used to investigate acetamide-45 on the airway lesions compared with glucocorticoids. The study was conducted on mice sensitized and challenged with ovalbumin and the whole body plethsmography was carried out to assess AHR. The bronchoalveolar lavage (BAL) histopathology was examined. Results: We found that acetamide-45 significantly inhibited the enhanced hyperresponsiveness and eosinophil recruitment in airways with elimination of cAMP-PDE activity in lung tissue. Elevated IL-4 and IL-5 in bronchoalveolar lavage fluid (BALF) in asthmatic mice were markedly decreased. Conclusion: Our results indicate that the agent has a potential role in inflammatory disease.

Keywords: 3′,5′-cyclic-nucleotide-phospho-diesterase; acetamide-45; asthma; hyperresponsiveness; lung

Document Type: Research Article

DOI: http://dx.doi.org/10.1111/j.1745-7254.2008.00846.x

Affiliations: 1: Department of Respiratory Medicine, Second Affiliated Hospital, Medical School of Zhejiang University, Hangzhou 310009, China 2: Department of Pharmacology, School of Zhejiang University, Hangzhou 310058, China

Publication date: October 1, 2008

bsc/aphs/2008/00000029/00000010/art00008
dcterms_title,dcterms_description,pub_keyword
6
5
20
40
5

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more